Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  1,910 results for ""Diabetes Mellitus, Type 2""

Your Filters

Publisher : wiley Subject : biomarkers Subject : diabetes mellitus, type 2 Subject : glucose intolerance Subject : heart failure Filter by : Subject
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Report

Integrated biomarker profiling of the metabolome associated with impaired fasting glucose and type 2 diabetes mellitus in large-scale Chinese patients.

  • Authors : Long J; Beijing Friendship Hospital, Capital Medical University, Beijing, China.; Beijing Key Laboratory for Evaluation of Rational Drug Use, Beijing, China.

Subjects: Biomarkers/Biomarkers/Biomarkers/*analysis ; Blood Glucose/Blood Glucose/Blood Glucose/*analysis ; Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/*diagnosis

  • Source: Clinical and translational medicine [Clin Transl Med] 2021 Jun; Vol. 11 (6), pp. e432.Publisher: Wiley Country of Publication: United States NLM ID: 101597971 Publication Model: Print Cited Medium: Internet

Record details

Read More Add to Saved list
×
Academic Journal

Using data on biomarkers and siblings to study early-life economic determinants of type-2 diabetes.

  • Authors : Alessie RJM; University of Groningen, Groningen, The Netherlands.; Netspar, Tilburg, The Netherlands.

Subjects: Diabetes Mellitus, Type 2* ; Siblings* ; Biomarkers*/Biomarkers*/Biomarkers*/blood

  • Source: Health economics [Health Econ] 2024 Jun; Vol. 33 (6), pp. 1266-1283. Date of Electronic Publication: 2024 Feb 25.Publisher: Wiley Country of Publication: England NLM ID: 9306780 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Editorial & Opinion

Association of sodium-glucose cotransporter 2 inhibitors with changes in comprehensive geriatric assessment in elderly diabetic patients with heart failure: Data from MAGIC-HF.

  • Authors : Armentaro G; Department of Medical and Surgical Sciences, 'Magna Græcia' University, Catanzaro, Italy.; Cassano V

Subjects: Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/therapeutic use ; Heart Failure*/Heart Failure*/Heart Failure*/drug therapy ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy

  • Source: European journal of heart failure [Eur J Heart Fail] 2024 Apr; Vol. 26 (4), pp. 1095-1097. Date of Electronic Publication: 2024 Apr 28.Publisher: Wiley Country of Publication: England NLM ID: 100887595 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Editorial & Opinion

Advancing the fight against fibrosis in patients with heart failure: The contribution of sodium-glucose cotransporter 2 inhibition.

  • Authors : de Boer RA; Thorax Center, Department of Cardiology, Erasmus Medical Center, Erasmus MC, Cardiovascular Institute, Rotterdam, The Netherlands.; Díez J

Subjects: Heart Failure*/Heart Failure*/Heart Failure*/drug therapy ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/complications ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy

  • Source: European journal of heart failure [Eur J Heart Fail] 2024 Feb; Vol. 26 (2), pp. 285-287. Date of Electronic Publication: Publisher: Wiley Country of Publication: England NLM ID: 100887595 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Clarifying the causal contrast: An empirical example applying the prevalent new user study design.

  • Authors : Young JC; Cecil G. Sheps Center for Health Services Research, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.; Real World Evidence & Patient Outcomes, CERobs Consulting, LLC, Wrightsville Beach, North Carolina, USA.

Subjects: Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/epidemiology ; Heart Failure*/Heart Failure*/Heart Failure*/drug therapy ; Heart Failure*/Heart Failure*/Heart Failure*/epidemiology

  • Source: Pharmacoepidemiology and drug safety [Pharmacoepidemiol Drug Saf] 2024 Apr; Vol. 33 (4), pp. e5790.Publisher: Wiley Country of Publication: England NLM ID: 9208369 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Erythropoietic response after intravenous iron in patients with heart failure and reduced ejection fraction with and without background treatment with sodium-glucose cotransporter 2 inhibitors.

  • Authors : Marques P; Department of Internal Medicine, Centro Hospitalar Universitário de São João, Porto, Portugal.; Department of Surgery and Physiology, Cardiovascular Research and Development Center (), Faculty of Medicine of the University of Porto, Porto, Portugal.

Subjects: Heart Failure*/Heart Failure*/Heart Failure*/complications ; Heart Failure*/Heart Failure*/Heart Failure*/drug therapy ; Iron Deficiencies*

  • Source: European journal of heart failure [Eur J Heart Fail] 2023 Dec; Vol. 25 (12), pp. 2191-2198. Date of Electronic Publication: 2023 Aug 24.Publisher: Wiley Country of Publication: England NLM ID: 100887595 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Editorial & Opinion

Sodium-glucose cotransporter 2 inhibitors on top of intravenous iron in patients with heart failure and iron deficiency: Any incremental effect?

  • Authors : Savarese G; Division of Cardiology, Department of Medicine, Karolinska Institutet, Stockholm, Sweden.; Heart, Vascular and Neurology Theme, Karolinska University Hospital, Stockholm, Sweden.

Subjects: Heart Failure*/Heart Failure*/Heart Failure*/complications ; Heart Failure*/Heart Failure*/Heart Failure*/drug therapy ; Iron Deficiencies*

  • Source: European journal of heart failure [Eur J Heart Fail] 2023 Dec; Vol. 25 (12), pp. 2199-2201. Date of Electronic Publication: 2023 Oct 31.Publisher: Wiley Country of Publication: England NLM ID: 100887595 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Editorial & Opinion

Growth differentiation factor-15 in sodium-glucose cotransporter 2 inhibition: Mechanistic insights from the EMPEROR program.

  • Authors : Seoudy H; Department of Internal Medicine III, Cardiology and Angiology, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany.; DZHK (German Centre for Cardiovascular Research), partner site Hamburg/Kiel/Lübeck, Kiel, Germany.

Subjects: Heart Failure* ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy; Humans

  • Source: European journal of heart failure [Eur J Heart Fail] 2024 Jan; Vol. 26 (1), pp. 165-166. Date of Electronic Publication: 2024 Jan 01.Publisher: Wiley Country of Publication: England NLM ID: 100887595 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

SGLT2 Inhibitors' Cardiovascular Benefits in Individuals Without Diabetes, Heart Failure, and/or Chronic Kidney Disease: A Systematic Review.

  • Authors : Khiali S; Department of Clinical Pharmacy, Faculty of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran.; Taban-Sadeghi M

Subjects: Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/metabolism ; Heart Failure*/Heart Failure*/Heart Failure*/drug therapy ; Renal Insufficiency, Chronic*/Renal Insufficiency, Chronic*/Renal Insufficiency, Chronic*/drug therapy

  • Source: Journal of clinical pharmacology [J Clin Pharmacol] 2023 Dec; Vol. 63 (12), pp. 1307-1323. Date of Electronic Publication: 2023 Aug 02.Publisher: Wiley Country of Publication: England NLM ID: 0366372 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Editorial & Opinion

Sodium-glucose cotransporter 2 inhibitors in heart failure with preserved ejection fraction and chronic obstructive pulmonary disease - No heterogeneity.

  • Authors : Hage C; Heart, Vascular and Neuro Theme, Karolinska University Hospital, Stockholm, Sweden.; Division of Cardiology, Department of Medicine, Karolinska Institutet, Stockholm, Sweden.

Subjects: Heart Failure*/Heart Failure*/Heart Failure*/drug therapy ; Pulmonary Disease, Chronic Obstructive*/Pulmonary Disease, Chronic Obstructive*/Pulmonary Disease, Chronic Obstructive*/drug therapy ; Diabetes Mellitus, Type 2*

  • Source: European journal of heart failure [Eur J Heart Fail] 2023 Nov; Vol. 25 (11), pp. 2091-2092. Date of Electronic Publication: 2023 Oct 03.Publisher: Wiley Country of Publication: England NLM ID: 100887595 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
  • 1-10 of  1,910 results for ""Diabetes Mellitus, Type 2""